IL161261A0 - Storage-stable fibrinogen solutions - Google Patents

Storage-stable fibrinogen solutions

Info

Publication number
IL161261A0
IL161261A0 IL16126102A IL16126102A IL161261A0 IL 161261 A0 IL161261 A0 IL 161261A0 IL 16126102 A IL16126102 A IL 16126102A IL 16126102 A IL16126102 A IL 16126102A IL 161261 A0 IL161261 A0 IL 161261A0
Authority
IL
Israel
Prior art keywords
storage
fibrinogen solutions
stable fibrinogen
stable
solutions
Prior art date
Application number
IL16126102A
Other languages
English (en)
Original Assignee
Christopher J Woolverton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christopher J Woolverton filed Critical Christopher J Woolverton
Publication of IL161261A0 publication Critical patent/IL161261A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
IL16126102A 2001-10-03 2002-10-03 Storage-stable fibrinogen solutions IL161261A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32696301P 2001-10-03 2001-10-03
PCT/US2002/031432 WO2003028743A1 (en) 2001-10-03 2002-10-03 Storage-stable fibrinogen solutions

Publications (1)

Publication Number Publication Date
IL161261A0 true IL161261A0 (en) 2004-09-27

Family

ID=23274526

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16126102A IL161261A0 (en) 2001-10-03 2002-10-03 Storage-stable fibrinogen solutions

Country Status (8)

Country Link
US (2) US20030091558A1 (ja)
EP (1) EP1450829A1 (ja)
JP (1) JP2005508925A (ja)
KR (1) KR20040058194A (ja)
CN (1) CN1606447A (ja)
CA (1) CA2462599A1 (ja)
IL (1) IL161261A0 (ja)
WO (1) WO2003028743A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005239613A (ja) * 2004-02-25 2005-09-08 Asahi Kasei Medical Co Ltd フィブリノーゲン組成液及びその製法
US7597687B2 (en) * 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
US8419722B2 (en) * 2004-10-29 2013-04-16 Spinal Restoration, Inc. Apparatus and method for injection of fibrin sealant in spinal applications
US8206448B2 (en) 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
US8403923B2 (en) * 2004-10-29 2013-03-26 Spinal Restoration, Inc. Injection of fibrin sealant in the absence of corticosteroids in spinal applications
US20110213464A1 (en) * 2004-10-29 2011-09-01 Whitlock Steven I Injection of fibrin sealant in the absence of corticosteroids in spinal applications
US7655026B2 (en) * 2006-01-31 2010-02-02 Warsaw Orthopedic, Inc. Expandable spinal rods and methods of use
CN102268083B (zh) * 2010-06-07 2014-05-14 北京赛升药业股份有限公司 脱端基纤维蛋白原及其制备方法和应用
EP2616550B1 (en) * 2010-09-15 2016-02-10 Debiopharm International SA Method for separating target molecules or particles from fibrinogen-containing samples including blood components
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL263679A (en) * 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and ingredients for preventing tissue adhesion

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
DE4202667C1 (ja) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
JP3591837B2 (ja) * 1994-02-17 2004-11-24 ニューヨーク・ブラッド・センター・インコーポレイテッド フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用
WO1999037680A1 (en) * 1998-01-23 1999-07-29 Csl Limited Purification of fibrinogen
WO2000029041A1 (de) * 1998-11-18 2000-05-25 Aventis Behring Gmbh Stabilisierte proteinzubereitungen für einen gewebekleber

Also Published As

Publication number Publication date
WO2003028743A1 (en) 2003-04-10
US20030091558A1 (en) 2003-05-15
CA2462599A1 (en) 2003-04-10
KR20040058194A (ko) 2004-07-03
JP2005508925A (ja) 2005-04-07
EP1450829A1 (en) 2004-09-01
US20060148698A1 (en) 2006-07-06
CN1606447A (zh) 2005-04-13

Similar Documents

Publication Publication Date Title
IL162369A0 (en) Storage-stable fibrin sealant
GB0106560D0 (en) Perfume encapsulates
IL161261A0 (en) Storage-stable fibrinogen solutions
AU2001280135A1 (en) Fibrinogen lowering agents
GB0118517D0 (en) Compound
GB0111618D0 (en) Dishwashing
IL161262A0 (en) Storage-stable human fibrinogen solutions
EP1394120A4 (en) DISINFECTANT
IL160539A0 (en) Anti-influenzal agents
DE60239325D1 (en) Überexpression von phosphoenolpyruvat-carboxylase
GB0115891D0 (en) Configuration manager
GB0216739D0 (en) Steriliser
HK1055215A1 (en) Power edger
GB0324680D0 (en) Cementitios mixtures
AU2002364393A1 (en) Dosed portion containing detergent
HK1041777A2 (en) Package
AU2002348493A1 (en) Storage-stable fibrinogen solutions
PL367864A1 (en) Novel combination
GB0117640D0 (en) Message syatems
GB0108110D0 (en) Keeps
AU149514S (en) Package
EG23586A (en) Haemagel solution
GB0103884D0 (en) Package
AU146259S (en) Face washer
AU146258S (en) Face washer